Stephen Mayo Sarepta Therapeutics, Inc. (SRPT) insider trading activity

Stephen Mayo is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 9,004 shares of SRPT, which is worth approximately $173,146. The most recent transaction as insider was on Mar 10, 2025, when has been sold 2,383 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9K

0% 3M change

35.99% 12M change

Total Value Held $173,146

Stephen Mayo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2025	BUY Grant, award, or other acquisition	-	2,383 Added 20.93%	9,004 Common Stock
Mar 05 2024	SELL Open market or private sale	$385,479 $122.96 p/Share	3,135 Reduced 32.13%	6,621 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	1,846 Added 15.91%	9,756 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	1,523 Added 16.15%	7,910 Common Stock
Nov 17 2022	SELL Open market or private sale	$94,311 $109.92 p/Share	858 Reduced 11.84%	6,387 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	-	2,953 Added 28.96%	7,245 Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	-	4,292 Added 50.0%	4,292 Common Stock

Also insider at

MRK

Merck & Co., Inc. Healthcare

Director

ALLO

Allogene Therapeutics, Inc. Healthcare

Director

Stephen Mayo

Rahway, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Value

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT

Account